GL1X · GenesisL1 explorer

MolNFT v1 · #98917 · protein

Crystal structure of tr-alpha bound to T4 in a second site

4LNX · Thyroid hormone receptor alpha: “Crystal structure of tr-alpha bound to T4 in a second site”. X-ray diffraction, 2 ligands (T44, T3), 4 pockets (best druggability 0.83). MolNFT v1 #98917 on GenesisL1: 3D structure, binding sites and…

PDB
4LNX
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thyroid hormone receptor alpha
UniProt
P10827
Ligands
T44, T3
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 65% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThyroid hormone receptor alphaprotein26365% helix, 5% strandP10827

Ligands and binding sites

  • T44 · 3,5,3',5'-tetraiodo-L-thyronine · ligand · chains A
  • T3 · 3,5,3'triiodothyronine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11910.830.9729T3
21000.410.7719empty
3770.330.7518empty
4630.290.7417empty

Modifications

Observed in the structure: 4 modified (artifact).

Compared structures

  • 4LNX · Crystal structure of TR-alpha bound to T4 in a second site · the same entry in another collection · chain A against A, TM-score 1.00
  • P10827 · AlphaFold monomer V2.0 prediction for thyroid hormone receptor alpha (P10827) · a predicted model of the same protein · chain A against A, TM-score 0.88

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.